Early detection of pathogenesis through biomarkers holds the key to controlling
hypertension and preventing cardiovascular complications. Metabolomics profiling acts as a …

Aim Essential hypertension (EH) is one of the most important public health problems
worldwide. However, the pathogenesis of EH is unclear and early diagnostic methods are …

Hypertension is a major modifiable risk factor that affects the global health burden. Despite
the availability of multiple antihypertensive drugs, blood pressure is often not optimally …

Background: No studies have examined whether the cord blood metabolome—a reflection
of in utero metabolism—influences blood pressure (BP) in children. Objectives: To examine …

Objective: Previous studies on the association between metabolic biomarkers and
hypertension have been limited by small sample sizes, low number of studied biomarkers …

X-linked hypophosphatemia (XLH) is a rare genetic disorder that increases fibroblast growth
factor 23 (FGF23). XLH patients have an elevated risk of early-onset hypertension. The …

Background. Studies in adults have shown that several metabolites across multiple
pathways are strongly associated with hypertension. However, as yet, to our knowledge, no …

Background and aims Identify novel metabolite associations with blood pressure (BP) salt-
sensitivity and hypertension. Methods and results The Genetic Epidemiology Network of Salt …

Objective This study aimed to reveal the urine metabolic change of endometrial cancer (EC)
patients during fertility-sparing treatment and establish non-invasive predictive models to …

Background Left ventricular diastolic dysfunction (LVDD) is an important precursor of heart
failure (HF), but little is known about its relationship with gut dysbiosis and microbial-related …